SICHUAN KELUN-BIOTECH BIOPHARMACEUT
(HKEX: 6990)
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. engages in the research and development, manufacture, and commercialization of novel drugs. It offers proprietary technology platforms focusing on the treatment of breast cancer, non-small cell lung cancer, gastrointestinal cancers, and colorectal cancer, as well as non-oncology diseases. The company was founded by Ge Xin Liu on November 22, 2016 and is headquartered in Chengdu, China.
170.700 -
-2.100
(-1.22%)
价格区间
165.000 - 174.800
(5.94%)
开盘
170.000
昨收
172.800
买
170.200
买盘
('000)
0.3
卖
170.700
卖盘
('000)
0.8
成交量
('000)
334.6
成交额
57,416,035
注释
-
查看所有活动
Loading Chart...
Please login to view stock data and analysis